Venus Concept - VERO Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $3.75
  • Forecasted Upside: 816.87 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.41
▲ +0.0045 (1.11%)

This chart shows the closing price for VERO by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Venus Concept Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VERO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VERO

Analyst Price Target is $3.75
▲ +816.87% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Venus Concept in the last 3 months. The average price target is $3.75, with a high forecast of $5.50 and a low forecast of $2.00. The average price target represents a 816.87% upside from the last price of $0.41.

This chart shows the closing price for VERO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 investment analysts is to buy stock in Venus Concept. This rating has held steady since June 2022, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/23/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/24/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/22/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/20/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/18/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/19/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/18/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/17/2022

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/24/2022BTIG ResearchLower TargetBuy$7.00 ➝ $5.50Low
11/12/2021Stifel NicolausLower TargetHold$2.50 ➝ $2.00Low
3/18/2021OppenheimerReiterated RatingBuy$4.00High
12/11/2020Maxim GroupReiterated RatingBuy$6.00Medium
12/8/2020Stifel NicolausInitiated CoverageHold$2.50High
11/16/2020OppenheimerUpgradeMarket Perform ➝ Outperform$4.00Low
10/20/2020LADENBURG THALM/SH SHInitiated CoverageBuy$6.00High
8/14/2020Maxim GroupReiterated RatingBuy$8.00High
8/13/2020BTIG ResearchReiterated RatingBuy$7.00High
7/16/2020BTIG ResearchReiterated RatingBuy$7.00Low
7/6/2020BTIG ResearchInitiated CoverageBuy$7.00Medium
5/14/2020OppenheimerReiterated RatingHoldHigh
4/1/2020Maxim GroupReiterated RatingBuy$8.00Medium
3/31/2020OppenheimerReiterated RatingOutperform ➝ Market PerformMedium
1/10/2020OppenheimerInitiated CoverageOutperformHigh
1/9/2020Maxim GroupUpgradeHold ➝ Buy$10.00High
(Data available from 8/18/2017 forward)

News Sentiment Rating

-0.45 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/20/2022
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/19/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/21/2022
  • 3 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/20/2022
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/20/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/19/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/19/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
8/18/2022

Current Sentiment

  • 0 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Venus Concept logo
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.
Read More

Today's Range

Now: $0.41
Low: $0.38
High: $0.41

50 Day Range

MA: $0.53
Low: $0.40
High: $0.68

52 Week Range

Now: $0.41
Low: $0.40
High: $2.70

Volume

5,920 shs

Average Volume

148,519 shs

Market Capitalization

$26.77 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.41

Frequently Asked Questions

What sell-side analysts currently cover shares of Venus Concept?

The following Wall Street analysts have issued research reports on Venus Concept in the last year: BTIG Research, and Stifel Nicolaus.
View the latest analyst ratings for VERO.

What is the current price target for Venus Concept?

2 Wall Street analysts have set twelve-month price targets for Venus Concept in the last year. Their average twelve-month price target is $3.75, suggesting a possible upside of 827.1%. BTIG Research has the highest price target set, predicting VERO will reach $5.50 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of $2.00 for Venus Concept in the next year.
View the latest price targets for VERO.

What is the current consensus analyst rating for Venus Concept?

Venus Concept currently has 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe VERO will outperform the market and that investors should add to their positions of Venus Concept.
View the latest ratings for VERO.

What other companies compete with Venus Concept?

How do I contact Venus Concept's investor relations team?

Venus Concept's physical mailing address is 235 YORKLAND BLVD SUITE 900, TORONTO A6, M2J 4Y8. The company's listed phone number is (888) 907-0115 and its investor relations email address is [email protected] The official website for Venus Concept is www.venusconcept.com. Learn More about contacing Venus Concept investor relations.